Patadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.

Dosage & Administration

The recommended dose of Patadin eye drops is 1 drop in the affected eye(s) two times daily.


Patients should be advised not to wear a contact lens if their eye is red. Olopatadine ophthalmic solution should not be used to treat contact lens related irritation. Benzalkonium Chloride, preservative of Patadin, may be absorbed by soft contact lenses. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least 10 minutes after instillation of Patadin eye drops before they insert their contact lenses. The treatment should be discontinued in the presence of an allergic reaction.


Use in Pregnancy & Lactation
Olopatadine was found not to be teratogenic in rats and rabbits. There are, however, no adequate and well controlled studies in pregnant women. This drug should be used in pregnant women only if the potential benefit justifies the potential risk to the fetus.


It is not known whether topical ocular administration could result in sufficient systemic absorption to produce detectable quantities in the human breast milk. Nevertheless, caution should be exercised when Patadin is administered to a nursing mother.

Product Details

Related Products

Levorex Tablet

Levocetirizine Dihydrochloride 5 mg

Patadin DS Eye Drop

Olopatadine 0.2%

Sodicrom DS Eye Drops

Sodium Cromoglicate 4%

Sodicrom Eye Drops

Sodium Cromoglicate 2%